obesity drug news today glp-1 World Health Organization recommends drugs for GLP-1 Agonists Weight Loss Drugs

Risk of aspiration pneumonitis after elective esophagogastroduodenoscopy in patients on glucagon-like peptide-1 receptor agonists

Especially for older adults who have the most to gain from a drug that lowers the risk of heart disease but also need to preserve muscle strength combining a muscle-preserving drug with GLP-1 agonists could be a big deal

Some brain imaging studies have demonstrated that depressed patients show neuronal atrophy and decreased volume of the cortex and limbic lobe regions, including the PFC and hippocampus

Ready to explore semaglutide treatment

JACC 65(20):21592169 Lavie CJ, Pandey A, Lau DH, Alpert MA, Sanders P (2017) Obesity and atrial fibrillation prevalence, pathogenesis, and prognosis: effects of weight loss and exercise